Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors

International Archives of Allergy and Immunology

Volumn 143, Issue SUPPL. 1, 2007, Pages 28-32

  Kaneko, Motoko ^a   Ishihara, Kenji ^a   Takahashi, Aki ^a   Hong, JangJa ^a,b,c   Hirasawa, Noriyasu ^a   Zee, OkPyo ^b   Ohuchi, Kazuo ^a,d  

^a TOHOKU UNIVERSITY   (Japan)

^b Sungkyunkwan University   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Differentiation; EoL 1 cells; Eosinophils; FIP1L1 PDGFRA; Histone deacetylase inhibitors

Indexed keywords

APICIDIN; BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STAT5 PROTEIN; TRICHOSTATIN A;

CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; EOSINOPHIL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BUTYRATES; CELL DIFFERENTIATION; CELL LINE, TUMOR; EOSINOPHILS; GENE EXPRESSION REGULATION, LEUKEMIC; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; HYPEREOSINOPHILIC SYNDROME; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PEPTIDES, CYCLIC; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RNA, MESSENGER; STAT5 TRANSCRIPTION FACTOR;

EID: 34249797291     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101401     Document Type: Conference Paper

References (26)

1. Izumi T, Kishimoto S, Takano T, Nakamura M, Miyabe Y, Nakata M, Sakanaka C, Shimizu T: Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation. Biochem J 1995;305:829-835.
2. Hara K, Hasegawa T, Ooi H, Koya T, Tanabe Y, Tsukada H, Igarashi K, Suzuki E, Arakawa M, Gejyo F: Inhibitory role of eosinophils on cell surface plasmin generation by bronchial epithelial cells: inhibitory effects of transforming growth factor β. Lung 2001;179:9-20.
3. Saito H, Bourinbaiar A, Ginsburg M, Minato K, Ceresi E, Yamada K, Machover D, Breard J, Mathe G: Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 1985;66:1233-1240.
4. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG: A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-1214.
5. Cools J, Quentmeier H, Huntly BJ, Marynen P, Griffin JD, Drexler HG, Glliland DG: The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 2004; 103:2802-2805.
6. Griffin JH, Leung J, Bruner RJ, Caligiuri MA, Briesewitz R: Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA 2003;100:7830-7835.
7. Sterner DE, Berger SL: Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 2000;64:435-459.
8. De Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003;370:737-749.
9. Grunstein M: Histone acetylation in chromatin structure and transcription. Nature 1997;389:349-352.
10. Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC: Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 2005;45:495-528.
11. Adcock IM, Ford P, Barnes PJ, Ito K: Epigenetics and airways disease. Respir Res 2006;7:21.
12. Darkin-Rattray SJ, Gurnett AM, Myers RW, Dulski PM, Crumley TM, Allocco JJ, Cannova C, Meinke PT, Colletti SL, Bednarek MA, Singh SB, Goetz MA, Dombrowski AW, Polishook JD, Schmatz DM: Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc Natl Acad Sci USA 1996;93:13143-13147.
13. Yoshida M, Nomura S, Beppu T: Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res 1987;47: 3688-3691.
14. Riggs MG, Whittaker RG, Neumann JR, Ingram VM: n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 1977;268:462-464.
15. Csordas A: On the biological role of histone acetylation. Biochem J 1990;265:23-38.
16. Pazin MJ, Kadonaga JT: What's up and down with histone deacetylation and transcription? Cell 1997;89:325-328.
17. Koyama Y, Adachi M, Sekiya M, Takekawa M, Imai K: Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis. Blood 2000;96: 1490-1495.
18. Ishihara K, Takahashi A, Kaneko M, Sugeno H, Hirasawa N, Hong J, Zee O, Ohuchi K: Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors. Life Sci 2007;80:1213-1220.
19. Sengupta N, Seto E: Regulation of histone deacetylase activities. J Cell Biochem 2004; 93:57-67.
20. Davie JR: Inhibition of histone deacetylase activity by butyrate. J Nutr 2003;133:2485S-2493S.
21. Komatsu Y, Tomizaki KY, Tsukamoto M, kato T, Nishino N, Sato S, Yamori T, Tsuruo T, Furumai R, Yoshida M, Horinouchi S, Hayashi H: Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Cancer Res 2001;61:4459-4466.
22. Ishihara K, Hong J, Zee O, Ohuchi K: Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. Br J Pharmacol 2004;142:1020-1030.
23. Ishihara K, Hong J, Zee O, Ohuchi K: Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate. Int Arch Allergy Immunol 2005;137(suppl 1):77-82.
24. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, Yoo MA, Song EJ, Lee KJ, Kim KW: Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 2002;111:709-720.
25. Bali P, Pranpat M, Bradner J, Balasis M, Fiskus W, Guo F, Rocha K, Kumaraswamy S, Boyapalle S, Atadja P, Seto E, Bhalla K: Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90:a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 2005;280:26729-26734.
26. Krämer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Göttlicher M: The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 2003;22:3411-3420.